Biotech Values

[rkrw]

I think what Jon may have been alluding to is assuming mnta is approved first, how do you discount the possibility that teva/amphastar (or someone else) isn't approved later? Unless teva/amphastar come out and say they were rejected and are giving up.

On the exclusivity quiz answer, mnta has said and maybe teva or amphastar would fight this and I'm not sure what precedent there is. If the patent is overturned within a few months (likely) and no generics are approved within 6 months of that(also likely imo), does the 6 month exclusivity period expire? mnta has stated this is the case.